Literature DB >> 18806218

Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol.

Jenny Vikman1, Javier Jimenez-Feltström, Per Nyman, Johan Thelin, Lena Eliasson.   

Abstract

Cholesterol-rich clusters of SNARE (soluble NSF attachment protein receptor) proteins have been implicated as being important for exocytosis. Here we demonstrate the significance of cholesterol for normal biphasic insulin secretion in mouse beta cells by removal of cholesterol from the plasma membrane using methyl-beta-cyclodextrin (MBCD). Maximal inhibition of insulin secretion in static incubations was achieved using 0.1 mM MBCD. In in situ pancreatic perfusion measurements, both first and second phase insulin secretions were reduced by approximately 50% (P<0.05). This was accompanied by a reduced number of docked large dense core vesicles (LDCVs) (approximately 40%; P<0.01) and a reduced exocytotic response (>50%; P<0.01). Further, subcellular fractionations demonstrated movement of the synaptosomal protein of 25 kDa (SNAP-25) from the plasma membrane to the cytosol after MBCD treatment. The inhibitory actions of MBCD were counteracted by subsequent addition of cholesterol. We hypothesize that desorption of cholesterol leads to the disturbance of a basic exocytotic mechanism partly due to migration of SNAP-25, and we conclude that insulin secretion is highly sensitive to changes in plasma membrane cholesterol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806218     DOI: 10.1096/fj.08-105734

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  31 in total

1.  An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.

Authors:  Jeffrey M Sturek; J David Castle; Anthony P Trace; Laura C Page; Anna M Castle; Carmella Evans-Molina; John S Parks; Raghavendra G Mirmira; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

3.  Glucose-dependent docking and SNARE protein-mediated exocytosis in mouse pancreatic alpha-cell.

Authors:  Sofia A Andersson; Morten G Pedersen; Jenny Vikman; Lena Eliasson
Journal:  Pflugers Arch       Date:  2011-06-04       Impact factor: 3.657

Review 4.  Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes.

Authors:  Liam R Brunham; Janine K Kruit; Michael R Hayden; C Bruce Verchere
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

Review 5.  Regulation of insulin secretion: role of mitochondrial signalling.

Authors:  S Jitrapakdee; A Wutthisathapornchai; J C Wallace; M J MacDonald
Journal:  Diabetologia       Date:  2010-03-12       Impact factor: 10.122

Review 6.  Influence of cholesterol on cellular signaling and fusion pore kinetics.

Authors:  Amy Tse; Andy K Lee; Lei Yan; Frederick W Tse
Journal:  J Mol Neurosci       Date:  2012-04-01       Impact factor: 3.444

Review 7.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

8.  Neuronal porosome proteome: Molecular dynamics and architecture.

Authors:  Jin-Sook Lee; Aleksandar Jeremic; Leah Shin; Won Jin Cho; Xuequn Chen; Bhanu P Jena
Journal:  J Proteomics       Date:  2012-05-29       Impact factor: 4.044

9.  Mathematical modeling of insulin secretion and the role of glucose-dependent mobilization, docking, priming and fusion of insulin granules.

Authors:  I Johanna Stamper; Xujing Wang
Journal:  J Theor Biol       Date:  2012-11-12       Impact factor: 2.691

10.  Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells.

Authors:  Julia E Maxson; Caroline A Enns; An-Sheng Zhang
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.